Stable Ischemic Heart Disease

Stable Ischemic Heart Disease

ACCF / American Heart Association Stable Ischemic Heart Disease GUIDELINES App. Printed Pocket Guide Available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/102910

Contents of this Issue

Navigation

Page 30 of 45

29 Alternative Therapies for Relief of Symptoms in Patients with Refractory Angina Î Enhanced external counterpulsation (EECP) may be considered for relief of refractory angina in patients with SIHD. (IIb–B) Î Spinal cord stimulation may be considered for relief of refractory angina in patients with SIHD. (IIb-C: No Benefit) Î Transmyocardial revascularization (TMR) may be considered for relief of refractory angina in patients with SIHD. (IIb-B) Î Acupuncture should not be used for the purpose of improving symptoms or reducing cardiovascular risk in patients with SIHD. (III-C: No Benefit) Additional Therapy to Reduce Risk of MI And Death Î NOT recommended with the intent of reducing cardiovascular risk or improving clinical outcomes: No Benefit • Estrogen therapy (III-A) • Vitamin C, vitamin E, and beta-carotene supplementation. (III-A) • Treatment of elevated homocysteine with folate or vitamins B6 and B12 (III-A) • Chelation therapy (III-C) • Garlic, coenzyme Q10, selenium, and chromium (III-C) Revascularization Î A Heart Team approach to revascularization is recommended in patients with unprotected left main or complex CAD. (I-C) Î Calculation of the STS (http://riskcalc.sts.org/STSWebRiskCalc273/ de.aspx) and SYNTAX (http://www.syntaxscore.com/calc/start.htm) scores is reasonable in patients with unprotected left main and complex CAD. (IIa-B)

Articles in this issue

Links on this page

Archives of this issue

view archives of Stable Ischemic Heart Disease - Stable Ischemic Heart Disease